The positive rates of FOXP1 were significantly lower in patients with poor differentiation, lymph node metastasis, invasion into surrounding organs, and advanced stages (p < 0.05). This evidence concerns the gene FOXP1 and metastatic malignant neoplasm in the lymph nodes.